Dipyridamole attenuates rebound pulmonary hypertension after inhaled nitric oxide withdrawal in postoperative congenital heart disease☆,☆☆,★,★★
Cited by (0)
- ☆
From the Pediatric Heart Lung Center and the Sections of Cardiology,a Neonatology,b and Pulmonary Medicine and Critical Care,c Department of Pediatrics, University of Colorado School of Medicine & The Children's Hospital, Denver, Colo., and Section of Cardiology,dDepartment of Pediatrics, Brown University, Providence, R.I.
- ☆☆
Supported by The Children's Hospital Research Institute Career Development Award (D.D.I., J.P.K.), the National Institutes of Health (H241012 and 46481; S.H.A.), the March of Dimes Birth Defects Foundation (D.D.I., J.P.K.), the Bugher Physician-Scientist Training Program (D.D.I., J.P.K.), and the American Heart Association Established Investigator Award (S.H.A.). Also supported by grant M01RR00069 General Clinical Research Centers, National Centers For Research Resources, National Institutes of Health.
- ★
Address for reprints: D. Dunbar Ivy, MD, Department of Cardiology, Box B100, The Children's Hospital, 1056 East 19th Ave., Denver, CO 80218.
- ★★
12/1/88057